International Journal of Radiation Oncology*Biology*Physics
Clinical InvestigationsExtracranial stereotactic radiation therapy: set-up accuracy of patients treated for liver metastases☆
Introduction
Radiation therapy has played a minor role in the treatment of patients with liver metastases. The tolerance dose of the whole liver to radiation is limited to 30 Gy, which does not result in longer survival (1). Higher doses could safely be applied to a liver tumor if functional liver tissue can be spared from high radiation doses (2). Stereotactic and conformal techniques made high-dose radiation therapy possible in the brain. However, in the brain, set-up accuracy of less than 2 mm can be achieved using invasive or non-invasive fixation methods 3, 4. In the bodytrunk, and especially in the liver, normal tissue sparing conformal therapy is complicated by an exact body-fixation and intra-corporal target movement. For paraspinal tumors, invasive and non-invasive methods for body fixation have been published 5, 6. However, these techniques are time consuming and not suitable for liver metastases, because they do not reduce the intra-corporal liver movement. Other repositioning devices have been used for conformal therapy of prostate cancer (7). Lax et al. (8) published a set-up for stereotactic radiation therapy of liver tumors using a vacuum pillow in a stereotactic frame. Using this device, an acceptable accuracy of repositioning for hypofractionated therapy could be achieved (8). We have used a similar approach for stereotactic treatment of liver metastases. We present our experience of set-up accuracy of the first 26 single dose treatments in patients with liver metastases.
Section snippets
Methods and materials
Between April 1997 and January 1999, 24 patients (17 male, 7 female) with inoperable metastases in the liver have been stereotactically treated in a phase I/II study in 26 occasions. The ethics committee of the University of Heidelberg approved the study, and all patients gave their written consent. The study design was in consent with the declaration of Helsinki (1975/1983). The median age was 60 years (range 49–84 years). The patients had a median body mass index [BMI = weight (kg)/(length (m)
Reduction of intra-corporal target movement
Fluoroscopy showed a median shift of the right diaphragm of 7 mm (range: 3–13 mm, mean 7.3 mm, standard deviation 2.7 mm). In seven patients, the movement of the posterior part of the diaphragm was also measured with lateral fluoroscopy since these patients had metastases in posterior parts of the liver. The posterior part of the right diaphragm showed a 2 mm (median; range 0–4 mm) stronger cranio-caudal shift than the frontal parts of the diaphragm in these patients.
There was a statistically
Discussion
Patients with metastases in the liver may benefit from surgery (10). However, liver resections are accompanied by a relatively high morbidity and mortality (11). Alternative methods to surgery have been developed for patients with inoperable hepatic disease. These included locoregional chemotherapy (12), laser-induced thermotherapy (LITT) (13), cryotherapy (14), alcohol injection (15), and also radiation therapy 1, 16, 17, 18, 19, 20. Due to the radiosensitivity of normal liver tissue,
Acknowledgements
The authors would like to thank Mrs. A. Fuxa, Mrs. M. Jochim, Mrs. S. Kuhn, and Mrs. C. Weyrich for their excellent technical support.
References (24)
- et al.
Accelerated hyperfractionated hepatic irradiation in the management of patients with liver metastasesresults of the RTOG dose escalating protocol
Int J Radiat Oncol Biol Phys
(1993) - et al.
The use of 3-D dose volume analysis to predict radiation hepatitis
Int J Radiat Oncol Biol Phys
(1992) Immobilizing and positioning patients for radiotherapy
Sem Rad Onc
(1995)- et al.
Noninvasive patient fixation for extracranial stereotactic radiotherapy
Int J Radiat Oncol Biol Phys
(1999) - et al.
Immobilization improves the reproducibility of patient position during six-field conformal radiation therapy for prostate carcinoma
Int J Radiat Oncol Biol Phys
(1993) - et al.
The treatment of colorectal liver metastases with conformal radiation therapy and regional chemotherapy
Int J Radiat Oncol Biol Phys
(1995) - et al.
A phase I trial of hepatic arterial bromodeoxyuridine and conformal radiation therapy for patients with primary hepatobiliary cancers or colorectal liver metastases
Int J Radiat Oncol Biol Phys
(1997) - et al.
Three-dimensional movement of a liver tumor detected by high-speed magnetic resonance
Radiother Oncol
(1999) - et al.
The use of active breath-ing control (ABC) to reduce margin for breathing motion
Int J Radiat Oncol Biol Phys
(1999) - et al.
Clinical efficacy of high frequency jet ventilation during extracorporal shock wave lithotripsy of renal and ureteral calculia comparison with conventional mechanical ventilation
J Urol
(1988)
Radiosurgery alone or in combination with whole-brain radiotherapy for brain metastases
J Clin Oncol
Preliminary clinical experience with linear accelerator-based spinal stereotactic radiosurgery
Neurosurgery
Cited by (177)
Stereotactic Body Radiation Therapy Versus Conventional Radiation Therapy in Pain Relief for Bone Metastases: A Systematic Review and Meta-Analysis
2023, International Journal of Radiation Oncology Biology PhysicsStage I Nonsmall Cell Lung Cancer and Oligometastatic Disease
2018, IASLC Thoracic OncologyImaged-guided liver stereotactic body radiotherapy using VMAT and real-time adaptive tumor gating. Concerns about technique and preliminary clinical results
2017, Reports of Practical Oncology and RadiotherapyDeep Inspiration Breath Hold - Based Radiation Therapy: A Clinical Review
2016, International Journal of Radiation Oncology Biology PhysicsStereotactic body radiation therapy for liver cancer: A review of the technology
2015, Journal of Medical Imaging and Radiation SciencesEffectiveness of oesophageal gastric junction tumour motion with and without a pneumatic abdominal compression belt in the era of precise image-guided radiation therapy
2023, International Journal of Radiation Research
- ☆
Supported in part by the Tumor Center Heidelberg/Mannheim (K.K.H.).